Please login to the form below

Not currently logged in
Email:
Password:

Spectrum Pharmaceuticals

This page shows the latest Spectrum Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

J&J’s bispecific lung cancer antibody nabs FDA breakthrough status

J&J’s bispecific lung cancer antibody nabs FDA breakthrough status

Last year, Spectrum Pharmaceuticals reported some data for its third-generation drug poziotinib in EGFR exon 20 insertion mutation-positive NSCLC, but was denied a breakthrough designation from the FDA.

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    8, 600. Trius Therapeutics / Cubist Pharmaceuticals. Acquisition. Antibiotic pipeline inc TR-701 (tedizolid phosphate, p3). ... 208. Talon Therapeutics / Spectrum Pharmaceuticals. Acquisition. Haemato-oncology portfolio, Marqibo for leukaemia (FDA

  • Pharma deals during July 2013 Pharma deals during July 2013

    Whilst the Elan and Perrigo deal creates a diversified business, several companies, such as Cubist, Ipsen and Spectrum Pharmaceuticals, focused on acquiring assets to bolster their core business areas in antibiotics, ... Following its $15m investment in

  • Pharma deals during March 2013 Pharma deals during March 2013

    Chinese traditional medicines and Western medicines. 70.5. Ligand Pharmaceuticals/ Spectrum Pharmaceuticals. ... Astellas Pharma/ Cubist Pharmaceuticals ††. Acquisition of rights. Ceftolozane for complicated Gram-negative infections.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics